2018-04-24 |
104 |
|
STIPULATION Regarding Infringement of U.S. Patent Nos. 7,709,517 and 8,183,274 by Astellas Pharma Inc., Astellas…December 2016
8 May 2019
1:16-cv-01120
830 Patent
None
District Court, D. Delaware
|
External link to document |
2018-04-26 |
105 |
|
Stipulation Regarding Infringement of U.S. Patent Nos. 7,709,517 and 8,183,274 filed by Medivation, Inc.,…December 2016
8 May 2019
1:16-cv-01120
830 Patent
None
District Court, D. Delaware
|
External link to document |
2018-11-20 |
154 |
|
Gelmann, M.D. on the Invalidity of U.S. Patent Nos. 7,709,517 and 8,183,274; and (2) Opening Expert Report…Brian S.J. Blagg on the Invalidity of U.S. Patent Nos. 7,709,517 and 8,183,274 filed by Cadila Healthcare…December 2016
8 May 2019
1:16-cv-01120
830 Patent
None
District Court, D. Delaware
|
External link to document |
2019-05-08 |
163 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2; 8,183,274 B2; 9,126,941…December 2016
8 May 2019
1:16-cv-01120
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-12-01 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2; 8,183,274 B2; 9,126,941…December 2016
8 May 2019
1:16-cv-01120
830 Patent
None
District Court, D. Delaware
|
External link to document |
2017-09-29 |
55 |
|
Proposed Construction of Claim Terms of U.S. Patent Nos. 7,709,517, 8,183,274, and 9,126,941 filed by Astellas…December 2016
8 May 2019
1:16-cv-01120
830 Patent
None
District Court, D. Delaware
|
External link to document |